Potential Carcinogen Prompts Recall Of Nearly 600,000 Bottles Of Blood Pressure Medication

The Food and Drug Administration (FDA) said drugmakers have recalled over 580,000 bottles of a blood pressure medication due to concerns it may include a potential carcinogen. According to CBS News, the agency said that “New Jersey-based drugmaker Teva Pharmaceuticals USA and drug distributor Amerisource Health Services issued voluntary nationwide recalls earlier this month of over half a million bottles of various strengths of prazosine capsules.” The FDA says more than 580,000 bottles of a blood pressure medication have been recalled over concerns that it may contain a cancer-causing chemical. https://t.co/bDF57lel3N— CBS News (@CBSNews) October 31, 2025CBS News shared more:...